ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q1SCImago #9,916Hybrid

Comparative Immunology Microbiology and Infectious Diseases

Acronym:cimid
•
Abbreviation (ISO):COMP IMMUNOL MICROB
•
Identifier (ISSN):0147-9571(Print)/1878-1667(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
2.5↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Comparative Immunology Microbiology and Infectious Diseases

WoS Q3
12341.9220181.8720191.5720202.2720212.7320222202322024220252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q1
0.596
#9,916

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
72

72 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
118articles/year
12.99% Gold OA•97.8% Original Research

Aims & Scope

Comparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine . The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology, parasitology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized. CIMID is mainly focusing on applied veterinary and human medicine rather than on fundamental experimental research.

Topics Covered (Recognized by AI)
Biology99%Medicine79.5%Genetics72.2%Immunology62.2%Virology51.9%Chemistry49%Biochemistry46.2%Internal medicine34.8%Pathology33%Microbiology31%Antibody30.4%Gene28.1%Geology25.1%Paleontology24.7%Virus23.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank128/183
IndexSCIE
JCRSCIE2026

MICROBIOLOGY

Q3
Rank114/167
IndexSCIE
JCRSCIE2026

VETERINARY SCIENCES

Q1
Rank40/170
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank93/183
IndexSCIE
JCISCIE2026

MICROBIOLOGY

Q3
Rank89/167
IndexSCIE
JCISCIE2026

VETERINARY SCIENCES

Q2
Rank76/170
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year55
Total Citations8
2025
IF2
Articles / Year85
Total Citations161
2024
IF2
Articles / Year102
Total Citations368
2023
IF2
Articles / Year103
Total Citations727
2022
IF2.729
Articles / Year117
Total Citations914

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,916Scopus Q1SCImago Profile
Scopus Coverage:1978-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicineVeterinary
Scopus Citation Rank (SJR)Q1
0.596

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.73

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,005 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations760
3-Year Documents292
Citable Documents287

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Veterinary (miscellaneous)Q1
Infectious DiseasesQ2
Medicine (miscellaneous)Q2
ImmunologyQ3
Immunology and AllergyQ3
MicrobiologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Agricultural Sciences
Minor Category (Specific Field):
4区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Comparative Immunology Microbiology and Infectious Diseases (acronym: cimid, abbr: COMP IMMUNOL MICROB, ISSN: 0147-9571) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England since 1978. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.596 (Q1), an H-index of 72.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 118 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,005 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
Multi-Language
Frequency
Bimonthly
Founding Year
1978
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cfe39a50-f2c8-49c6-945c-ac6fedf44418
Database Updated: 2026-10-16